NFJ Investment Group LLC Lowers Holdings in Teleflex Incorporated (NYSE:TFX)

NFJ Investment Group LLC lowered its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 12.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 164,087 shares of the medical technology company's stock after selling 22,828 shares during the period. NFJ Investment Group LLC owned about 0.35% of Teleflex worth $29,204,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TFX. Geode Capital Management LLC lifted its stake in shares of Teleflex by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after buying an additional 8,307 shares during the last quarter. Cooke & Bieler LP lifted its stake in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after purchasing an additional 195,150 shares during the period. Invesco Ltd. boosted its stake in Teleflex by 48.1% in the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Teleflex by 38.1% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock valued at $105,102,000 after acquiring an additional 162,950 shares during the period. Finally, Norges Bank acquired a new position in Teleflex in the fourth quarter valued at about $100,328,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Down 2.3 %

NYSE TFX traded down $2.98 on Monday, reaching $126.50. The company had a trading volume of 71,656 shares, compared to its average volume of 1,043,248. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $5.87 billion, a P/E ratio of 25.15, a P/E/G ratio of 1.73 and a beta of 1.19. The company's fifty day moving average is $143.68 and its 200 day moving average is $177.07. Teleflex Incorporated has a 52-week low of $124.66 and a 52-week high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.08%. Teleflex's payout ratio is 95.77%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on TFX. Mizuho set a $155.00 target price on Teleflex in a research note on Wednesday, April 16th. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Truist Financial cut their target price on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, Morgan Stanley dropped their price target on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $169.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.